Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 295
Selected: 0
NCT IDTitle
NCT02892123Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
NCT05720494A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants
NCT04984278Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis
NCT05229588Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
NCT04006925Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate
NCT01610713An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
NCT00003966Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
NCT00822094Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
NCT03295396ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
NCT07156435Vyxeos® With Clofarabine for Pediatric AML
NCT07813663A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female Participants
NCT02091375Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)
NCT01143181Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses
NCT05091567A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
NCT05126433Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
NCT00358501Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients
NCT02565108A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
NCT05152147A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
NCT04899050Epidiolex in Typical Absence Seizures
NCT02224703GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
NCT00711880A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.
NCT03485729ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
NCT03030599A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
NCT02369471A Study of GWP42006 in People With Focal Seizures - Part A
NCT02056782A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia
NCT00875693A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
NCT04217278A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT
NCT00675948Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
NCT04425655Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.
NCT02087306Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection
NCT01485770A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
NCT05580562ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
NCT05027139A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer
NCT02525692Oral ONC201 in Adult Recurrent Glioblastoma
NCT04485104Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
NCT02257684A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)
NCT03878199Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
NCT03032016European VOD Registry
NCT04224272A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer
NCT01323569Abuse Potential of Sativex
NCT04617002Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
NCT04389840Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure
NCT02607891A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
NCT02167685The Chimerix CMX001 Registry
NCT00106860A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
NCT02420080A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
NCT00931164Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO)
NCT04466891A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
NCT00097708Experimental Medication For the Treatment of Generalized Anxiety Disorder
NCT06695845A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors